| Literature DB >> 23668404 |
Kevin Beattie1, Geeta Phadke, Jasmina Novakovic.
Abstract
Carvedilol ((2RS)-1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol), a β1-, β2-, and α1-adrenoreceptor blocker drug with antioxidant and antiproliferative effects, is indicated for treatment of hypertension, stable angina pectoris, and congestive heart failure. A profile of this drug substance is provided in this chapter and includes physical characteristics of Carvedilol (e.g., UV-vis, IR, NMR, and mass spectra). Details regarding the stability of Carvedilol in the solid state and solution phase are presented and methods of analysis (compendial and literature) are summarized. Furthermore, an account of the pharmacokinetics (ADME) and synthesis of Carvedilol are presented.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23668404 DOI: 10.1016/B978-0-12-407691-4.00004-6
Source DB: PubMed Journal: Profiles Drug Subst Excip Relat Methodol ISSN: 1871-5125